These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 26091869)
1. Occurrence, ecotoxicological effects and risk assessment of antihypertensive pharmaceutical residues in the aquatic environment--A review. Godoy AA; Kummrow F; Pamplin PA Chemosphere; 2015 Nov; 138():281-91. PubMed ID: 26091869 [TBL] [Abstract][Full Text] [Related]
2. Occurrence and ecotoxicological assessment of pharmaceuticals: Is there a risk for the Mediterranean aquatic environment? Desbiolles F; Malleret L; Tiliacos C; Wong-Wah-Chung P; Laffont-Schwob I Sci Total Environ; 2018 Oct; 639():1334-1348. PubMed ID: 29929299 [TBL] [Abstract][Full Text] [Related]
3. Beta-blockers in the environment: part II. Ecotoxicity study. Maszkowska J; Stolte S; Kumirska J; Łukaszewicz P; Mioduszewska K; Puckowski A; Caban M; Wagil M; Stepnowski P; Białk-Bielińska A Sci Total Environ; 2014 Sep; 493():1122-6. PubMed ID: 24975494 [TBL] [Abstract][Full Text] [Related]
4. Ecotoxicological evaluation of propranolol hydrochloride and losartan potassium to Lemna minor L. (1753) individually and in binary mixtures. Godoy AA; Kummrow F; Pamplin PA Ecotoxicology; 2015 Jul; 24(5):1112-23. PubMed ID: 25847105 [TBL] [Abstract][Full Text] [Related]
5. Exposure and ecotoxicological risk assessment of mixtures of top prescribed pharmaceuticals in Swedish freshwaters. Lindim C; de Zwart D; Cousins IT; Kutsarova S; Kühne R; Schüürmann G Chemosphere; 2019 Apr; 220():344-352. PubMed ID: 30590300 [TBL] [Abstract][Full Text] [Related]
6. Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol. Küster A; Alder AC; Escher BI; Duis K; Fenner K; Garric J; Hutchinson TH; Lapen DR; Péry A; Römbke J; Snape J; Ternes T; Topp E; Wehrhan A; Knacker T Integr Environ Assess Manag; 2010 Jul; 6 Suppl():514-23. PubMed ID: 19886730 [TBL] [Abstract][Full Text] [Related]
7. Ecotoxicological risk assessment of chosen pharmaceuticals detected in surface waters. Załęska-Radziwiłł M; Affek K; Doskocz N J Environ Sci Health A Tox Hazard Subst Environ Eng; 2017 Nov; 52(13):1233-1239. PubMed ID: 28949837 [TBL] [Abstract][Full Text] [Related]
8. Occurrence and toxicity of antibiotics in the aquatic environment: A review. Kovalakova P; Cizmas L; McDonald TJ; Marsalek B; Feng M; Sharma VK Chemosphere; 2020 Jul; 251():126351. PubMed ID: 32443222 [TBL] [Abstract][Full Text] [Related]
9. Ecotoxicology of human pharmaceuticals. Fent K; Weston AA; Caminada D Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063 [TBL] [Abstract][Full Text] [Related]
10. Drug residues in urban water: A database for ecotoxicological risk management. Destrieux D; Laurent F; Budzinski H; Pedelucq J; Vervier P; Gerino M Sci Total Environ; 2017 Dec; 609():927-941. PubMed ID: 28783905 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms. Mezzelani M; Gorbi S; Regoli F Mar Environ Res; 2018 Sep; 140():41-60. PubMed ID: 29859717 [TBL] [Abstract][Full Text] [Related]
12. Modification of the Microtox® Basic Solid Phase Test: A new application for the ecotoxicological studies on poorly soluble antihypertensive drugs. Turek M; Różycka-Sokołowska E; Owsianik K; Marciniak B; Bałczewski P J Hazard Mater; 2020 Nov; 399():122839. PubMed ID: 32526424 [TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors and β-blocker transformation products may not pose a significant risk of toxicity to aquatic organisms in wastewater effluent-dominated receiving waters. Brown AK; Challis JK; Wong CS; Hanson ML Integr Environ Assess Manag; 2015 Oct; 11(4):618-39. PubMed ID: 25820351 [TBL] [Abstract][Full Text] [Related]
14. Bioaccumulation and analytics of pharmaceutical residues in the environment: A review. Puckowski A; Mioduszewska K; Łukaszewicz P; Borecka M; Caban M; Maszkowska J; Stepnowski P J Pharm Biomed Anal; 2016 Aug; 127():232-55. PubMed ID: 26968887 [TBL] [Abstract][Full Text] [Related]
15. The potential ecotoxicological impact of pharmaceutical and personal care products on humans and freshwater, based on USEtox™ characterization factors. A Spanish case study of toxicity impact scores. Ortiz de García S; García-Encina PA; Irusta-Mata R Sci Total Environ; 2017 Dec; 609():429-445. PubMed ID: 28755593 [TBL] [Abstract][Full Text] [Related]
16. Lanthanide ecotoxicity: first attempt to measure environmental risk for aquatic organisms. González V; Vignati DA; Pons MN; Montarges-Pelletier E; Bojic C; Giamberini L Environ Pollut; 2015 Apr; 199():139-47. PubMed ID: 25645063 [TBL] [Abstract][Full Text] [Related]
17. Effects of commonly used therapeutic drugs, paracetamol, and acetylsalicylic acid, on key physiological traits of the sea snail Gibbula umbilicalis. Giménez V; Nunes B Environ Sci Pollut Res Int; 2019 Jul; 26(21):21858-21870. PubMed ID: 31134547 [TBL] [Abstract][Full Text] [Related]
18. Environmental behavior and eco-toxicity of xylene in aquatic environments: A review. Duan W; Meng F; Wang F; Liu Q Ecotoxicol Environ Saf; 2017 Nov; 145():324-332. PubMed ID: 28756253 [TBL] [Abstract][Full Text] [Related]
19. Pesticidal copper (I) oxide: environmental fate and aquatic toxicity. Kiaune L; Singhasemanon N Rev Environ Contam Toxicol; 2011; 213():1-26. PubMed ID: 21541846 [TBL] [Abstract][Full Text] [Related]
20. Occurrence, hazard, and risk of psychopharmaceuticals and illicit drugs in European surface waters. Davey CJE; Kraak MHS; Praetorius A; Ter Laak TL; van Wezel AP Water Res; 2022 Aug; 222():118878. PubMed ID: 35878520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]